Health Canada Authorizes First GLP-1 Pill to Reduce Heart Attack and Stroke Risk
Health Canada authorizes RYBELSUS® as the first oral GLP-1 to reduce heart attack and stroke risk in adults with type 2 diabetes.
Confronting the Silence Around Dementia: Why Not Knowing Isn’t a Strategy
New data reveals Canadians are avoiding dementia diagnoses and how facing the facts early can preserve your independence and health.
The Mood Menu: How Your Plate Shapes Your Mind
Discover how simple food choices like turkey and yogurt can boost your serotonin and stabilize your mood.
Health Canada Authorizes First 8-Week Treatment for Acute Hepatitis C
Health Canada’s approval of MAVIRET for acute HCV allows doctors to treat adults and children immediately, a key step toward the 2030 elimination goal.
The 7-Day Reset: A Social Media Break Can Transform Your Mental Health
Discover why science says you only need one week off social media to lower anxiety and sleep better. A practical guide for the modern Canadian.
The Science of Sweat: How Saunas Boost Heart & Brain Health
Explore the life-extending benefits of sauna use. Compare traditional and infrared costs, health benefits and safety in our expert guide.
Leftovers Safety: Store & Reheat Like a Pro
Learn how to store and reheat holiday leftovers safely. From the "Two-Hour Rule" to freezing tips, keep your Canadian kitchen healthy this season.
Guilt-Free Indulgence for the Holidays. This is How it’s Done.
Enjoy every plate this season! Prep your gut with our low-effort tips: boost hydration, sip digestive tea, and avoid the post-feast crash.
Health Canada Authorizes TNKase for Treatment of Adult Stroke
Health Canada officially authorizes TNKase for treating acute ischemic stroke in adults. This pivotal approval introduces a faster, 5-second injection to emergency rooms nationwide.
Generic Ozempic: Canada to See Significant Price Drops
Struggling with high medication costs? Generic Ozempic is coming to Canada in 2026. Learn how prices could drop from $400 to around $100.
Wegovy Authorized as Canada’s First Liver Disease Drug
No more "watchful waiting." Health Canada’s approval of Wegovy gives MASH patients their first tangible medical option to fight liver fibrosis.
Canada Authorizes First-Ever Oral Treatment for Postpartum Depression
Canada approves ZURZUVAE, the first oral PPD pill. This breakthrough 14-day oral therapy aims to elevate the standard of maternal mental health care.